← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2011Last known activity
Apr 30, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT03128216Lead sponsorN/AApr 30, 2017
- NCT03128216Reponsible party - principal investigatorN/AApr 30, 2017
- NCT02681562Lead sponsorPhase 2Jan 1, 2016
- NCT02681562Reponsible party - principal investigatorPhase 2Jan 1, 2016
- NCT02677571Lead sponsorN/ADec 1, 2015
- NCT02677571Study directorN/ADec 1, 2015
- NCT02677571Reponsible party - principal investigatorN/ADec 1, 2015
- NCT02616848Reponsible party - principal investigatorPhase 1Nov 1, 2015
- NCT02616848Lead sponsorPhase 1Nov 1, 2015
- NCT02178033CollaboratorN/AJan 1, 2014
- NCT02077777Overall official - principal investigatorPhase 2Oct 1, 2012
- NCT01552148Reponsible party - principal investigatorPhase 4Mar 1, 2012
- NCT01552148Lead sponsorPhase 4Mar 1, 2012
- NCT01681563Overall official - principal investigatorPhase 2Sep 1, 2011
Details
- Founded
- Cremona, IT
- Last known activity
- Apr 30, 2017